Recent trends in the development of enabled drug products containing spray-dried dispersions (SDDs) demonstrate the need for early determination of process and product risk throughout the development lifecycle to reduce development time and material cost.
These risks can help inform development strategies to bolster process knowledge from early clinical manufactures up through process performance qualification (PPQ), bolstering the overall time available for process optimization prior to commercialization.
This discussion will highlight the overall process qualification lifecycle for SDDs and the strategies that Seràn BioScience typically uses to support SDD intermediates throughout this process using a “Right from the Start” philosophy.
These strategies are aimed at informing process decisions early in the development lifecycle while minimizing development API requirements to minimize process risk, accelerate timelines, and overall improve patient outcomes.
What you will learn:
Who should attend:
Please check the highlighted fields and try again.
Please enter your mailing address.